Welcome to UCB in Canada

Improving the lives of Canadians with severe diseases—everything else follows.

Group shot of UCB employees posing on a large office staircase

A word from our leadership

UCB Canada is dedicated to delivering life-changing medicines through science, driven by a commitment to patients.

Man with a large smile holds his son on his back, who is also smiling.

Our Medicines

UCB's medicines are making a real difference in the lives of patients all over the world.

A doctor holds her hand up as she speaks with a patient.

UCBCares® for HCPs

Get access to scientific information and additional resources in dermatology and rheumatology, or neurology.

Press release
UCB Canada marks 20 years of advancing care and innovation in Canada

From clinical research and patient support to partnerships that address gaps in care, UCB Canada reflects on two decades of growth and looks to its next chapter

Press release
PrZILBRYSQ® Now Publicly Reimbursed in Ontario for Generalized Myasthenia Gravis

Reimbursement decision provides eligible Ontarians living with generalized myasthenia gravis with an additional treatment option that may offer greater flexibility, independence, and individualized care.

Press release
UCB Canada Therapies Gain Broad Coverage Across Canada for the Treatment of Generalized Myasthenia Gravis (gMG)

PrRYSTIGGO® (rozanolixizumab injection) and PrZILBRYSQ® (zilucoplan injection) are now publicly reimbursed in multiple provinces in Canada, as well as through Veterans Affairs Canada and the Non-Insured Health Benefits Program.

UCB Canada is a proud member of BIOTECanada, IMC and RAREi.